Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and
暂无分享,去创建一个
P. Sonneveld | A. Hagemeijer | Z. Berneman | E. Archimbaud | B. Löwenberg | R. Zittoun | S. Suciu | G. Fillet | G. Solbu | G. Visani | A. Thyss | M. Hayat | H. Haak | A. Dekker | P. Stryckmans | J. van der Lelie | R. de Cataldo | J. Lelievander | R. Cataldode